
Opinion|Videos|May 8, 2024
Impact of the Introduction of Bispecifics on the Management of Multiple Myeloma
Ke Ning, MD, discusses the impact of the introduction of bispecific antibodies for treating patients with relapsed or refractory multiple myeloma.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Polycystic Ovary Syndrome Undergoes Name Change: Polyendocrine Metabolic Ovarian Syndrome
2
Ketamine’s Expanding Role in Chronic Pain and Opioid-Sparing Therapy
3
Navigating GLP-1 Access: A Pharmacy Technician’s Role
4
Pharmacy Care Under Pressure: Pairing Standard Practice with Always-On Surveillance for Safer, More Efficient Care
5



































































































































